文献详情页索引 · 第 7 页

第 3,001–3,500 个,共 8,991 个页面。

  1. 起源于睾丸畸胎瘤的肝细胞癌:一种独特且未被认识的继发性体细胞恶性肿瘤

    Hepatocellular carcinoma arising in a testicular teratoma: a distinct and unrecognized secondary somatic malignancy.

  2. 一例埃及果蝠(Rousettus aegyptiacus)肝细胞癌伴肺转移显示血色沉着症

    Hepatocellular carcinoma with lung metastasis showing hemochromatosis in an Egyptian fruit bat (Rousettus aegyptiacus).

  3. 肝细胞癌降期治疗的规则应如何制定?

    What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?

  4. 晚期肝细胞癌当前和新兴疗法综述

    A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma.

  5. 肝细胞癌

    Hepatocellular Carcinoma.

  6. H-TEX介导的肝细胞癌细胞和巨噬细胞之间的信号传导以及肝细胞癌的外泌体靶向治疗

    H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma.

  7. 红细胞分布宽度在根治性切除术后肝细胞癌患者中的意义

    The significance of RDW in patients with hepatocellular carcinoma after radical resection.

  8. 肝移植后复发性肝细胞癌的非典型表现

    Atypical Presentation of Recurrent Hepatocellular Carcinoma After Liver Transplant.

  9. 线粒体移植疗法抑制恶性肝细胞癌增殖及其机制

    Mitochondrial transplantation therapy inhibits the proliferation of malignant hepatocellular carcinoma and its mechanism.

  10. 一例布加综合征患儿肝细胞癌破裂

    Ruptured Hepatocellular Carcinoma in a Child with Budd-Chiari Syndrome.

  11. 乙型肝炎和肝细胞癌

    Hepatitis B and Hepatocellular Carcinoma.

  12. 纤维板层型肝细胞癌的管理

    Management of fibrolamellar hepatocellular carcinoma.

  13. 一例蝶窦转移性肝细胞癌

    A case of metastatic hepatocellular carcinoma of the sphenoid sinus.

  14. 病例报告:远端胰腺的肝细胞癌转移

    Case report: A hepatocellular carcinoma metastasis in the distal pancreas.

  15. 不适合手术切除的老年肝细胞癌患者的临床特征与预后

    Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection.

  16. 厦门市肝细胞癌的流行病学和临床特征

    Epidemiological and clinical characteristics of hepatocellular carcinoma in Xiamen.

  17. 视频辅助膈肌切除与重建治疗肝细胞癌胸腔内复发

    Video-assisted diaphragmatic resection and reconstruction for intra-thoracic recurrence of hepatocellular carcinoma.

  18. 过去十年间肝细胞癌诊断指南的变化

    Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.

  19. 肝细胞癌中的代谢重编程:免疫逃避机制和治疗意义

    Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications.

  20. 类花生酸与肝细胞癌发病机制关联的生物分析见解

    Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma.

  21. [肝细胞癌的非手术治疗]

    [Nonsurgical management of hepatocellular carcinoma].

  22. 肝细胞癌破裂出血后围手术期死亡的危险因素分析

    Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma.

  23. 肝细胞癌血管侵犯影像学的临床意义

    Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.

  24. 通过无标记定量蛋白质组学鉴定口腔鳞状细胞癌赖氨酸乙酰化组

    Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomics.

  25. 槟榔诱导的颊黏膜成纤维细胞收缩及其信号传导:在口腔黏膜下纤维化——一种癌前病变中的潜在作用

    Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.

  26. 丹参素钠通过调节p38信号通路抑制口腔癌细胞迁移和侵袭

    Sodium Danshensu Inhibits Oral Cancer Cell Migration and Invasion by Modulating p38 Signaling Pathway.

  27. 番茄红素:在口腔癌和癌前病变中的特征及潜在意义

    Lycopene: features and potential significance in the oral cancer and precancerous lesions.

  28. 二甲双胍在缺氧条件下增加PDH并抑制HIF-1α,并诱导口腔鳞状细胞癌细胞死亡

    Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.

  29. p38 MAPK通路对5,5'-二溴二吲哚基甲烷诱导的凋亡以预防口腔鳞癌细胞至关重要

    The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.

  30. 中子放射自显影研究口腔癌模型中硼化合物的微分布

    Neutron autoradiography to study boron compound microdistribution in an oral cancer model.

  31. 循环肿瘤来源线粒体NADH亚基变异的定量检测作为口腔癌潜在预后生物标志物

    Quantitative detection of circulating tumor-derived mitochondrial NADH subunit variants as a potential prognostic biomarker for oral cancer.

  32. 口腔鳞状细胞癌中CHFR基因启动子异常高甲基化

    Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

  33. VEGF与口腔癌细胞迁移之间存在pAkt吗?

    Is there a pAkt between VEGF and oral cancer cell migration?

  34. M2极化巨噬细胞促进新生血管形成,导致放疗后口腔癌复发

    M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation.

  35. 癌相关成纤维细胞中的糖酵解重编程通过lncRNA H19/miR-675-5p/PFKFB3信号通路促进口腔癌生长

    Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway.

  36. 口腔癌中TGFBR2异常剪接的早期表现、肿瘤特异性发生及预后意义

    The early manifestation, tumor-specific occurrence and prognostic significance of TGFBR2 aberrant splicing in oral carcinoma.

  37. HOXA3的表观遗传调控及其对口腔鳞状细胞癌进展的影响

    Epigenetic regulation of HOXA3 and its impact on oral squamous cell carcinoma progression.

  38. B细胞淋巴瘤/白血病10通过STAT1/ATF4/S100P信号通路促进口腔癌进展

    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.

  39. 无烟烟草的化学成分与致癌性

    Chemical composition and carcinogenicity of smokeless tobacco.

  40. 吴茱萸碱在人口腔癌细胞系中抗癌潜力的体外评估

    In Vitro Assessment of the Anticancer Potential of Evodiamine in Human Oral Cancer Cell Lines.

  41. CEBPG介导的癌相关成纤维细胞棕榈酸适应性驱动口腔鳞状细胞癌转移

    CEBPG-Mediated Palmitic Acid Adaptation of Cancer-Associated Fibroblasts Drives Metastasis of Oral Squamous Cell Carcinoma.

  42. 槲皮素通过p38 MAPK-Hsp27凋亡通路抑制口腔癌细胞中的耐药球体

    Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.

  43. 探索口腔癌中被DNA高甲基化沉默的肿瘤抑制性微小RNA

    Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

  44. 蛋白酶体激活因子28γ的新型转录变体:在口腔癌细胞中的鉴定和功能

    A novel transcript variant of proteasome activator 28γ: Identification and function in oral cancer cells.

  45. 整合计算化学、网络药理学和体外实验测定以解析天然来源倍半萜内酯-小白菊内酯对人02口腔癌细胞的抗肿瘤作用

    Integrating computational chemistry, network pharmacology and in vitro experimental assays for deciphering the antitumor effects of naturally occurring sesquiterpene lactone-parthenolide in human oral carcinoma cells.

  46. Snail通过RhoA/Cdc42/p-ERM通路调控口腔癌细胞的运动能力

    Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway.

  47. 香烟烟雾和唾液对淋巴细胞的协同效应——挥发性醛类和氧化还原活性铁的介导作用及其对口腔癌的可能意义

    Synergistic effect of cigarette smoke and saliva on lymphocytes--the mediatory role of volatile aldehydes and redox active iron and the possible implications for oral cancer.

  48. Dickkopf-1在人类口腔癌中的作用

    Dickkopf-1 in human oral cancer.

  49. 分析感染具核梭杆菌的口腔上皮细胞中差异表达基因以揭示与口腔癌相关的基因

    Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer.

  50. 氟西汀对OC2人口腔癌细胞[Ca²⁺]i和细胞活力的影响

    Effect of fluoxetine on [Ca²⁺]i and cell viability in OC2 human oral cancer cells.

  51. R2TP在口腔鳞状细胞癌发展中的鉴定与表征

    Identification and characterization of R2TP in the development of oral squamous cell carcinoma.

  52. S-1,一种口服氟嘧啶类抗癌药物,在体内和体外增强人口腔癌细胞系的放射敏感性:可能涉及抑制存活信号Akt/PKB

    S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt/PKB.

  53. 长链非编码RNA SLC7A11反义RNA1通过调节K同源型剪接调节蛋白的泛素化促进口腔鳞状细胞癌进展

    Long non-coding RNA SLC7A11 antisense RNA1 promotes oral squamous cell carcinoma progression by regulating ubiquitination of K-homology type splicing regulatory protein.

  54. 来自金露梅(Potentilla fulgens Wall. ex Sims)根部的生物活性儿茶素通过调节氧化应激、炎症和凋亡通路改善口腔癌变

    Bioactive catechins from Potentilla fulgens Wall. ex Sims roots ameliorate oral carcinogenesis through modulation of oxidative stress, inflammatory, and apoptotic pathways.

  55. 虾青素通过靶向口腔鳞状细胞癌模型中的PI3K/NF-κB/STAT3信号轴抑制癌症标志性特征

    Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models.

  56. 芬地林诱导的人口腔癌细胞[Ca2+]i升高及非Ca2+触发的细胞死亡

    Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells.

  57. {"_":"m6A修饰在口腔癌中的作用(综述)。","sup":["6"]}

    {"_":"Roles of mA modification in oral cancer (Review).","sup":["6"]}

  58. 含碳硼烷的卟啉作为靶向剂用于仓鼠颊囊口腔癌硼中子俘获治疗的生物分布研究

    Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.

  59. 通过整合蛋白质-蛋白质相互作用、基因本体论、通路分析和免疫组织化学鉴定口腔癌相关候选基因

    Identification of oral cancer related candidate genes by integrating protein-protein interactions, gene ontology, pathway analysis and immunohistochemistry.

  60. 薯蓣皂苷内酯糖苷对口腔鳞癌细胞在体外和体内的凋亡效应

    Apoptotic effects of diosgeninlactoside on oral squamous carcinoma cells in vitro and in vivo.

  61. 口腔鳞状细胞癌mRNA和miRNA的整合生物信息学分析识别潜在生物标志物

    Integrated Bioinformatics Analysis of mRNAs and miRNAs Identified Potential Biomarkers of Oral Squamous Cell Carcinoma.

  62. 大麻素抑制人口腔癌细胞的细胞呼吸

    Cannabinoids inhibit cellular respiration of human oral cancer cells.

  63. 在口腔癌模型中,电穿孔增强GB-10介导的体内BNCT治疗效果

    Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer.

  64. Cratoxylum Formosum Subsp. Pruniflorum Gogel提取物对口腔癌细胞系的细胞毒性

    Cytotoxicity of Cratoxylum Formosum Subsp. Pruniflorum Gogel Extracts in Oral Cancer Cell Lines.

  65. 口腔鳞状细胞癌核苷酸代谢关键基因的生物信息学鉴定与功能分析

    Bioinformatics Identification and Functional Analysis of Key Genes of Nucleotide Metabolism in Oral Squamous Cell Carcinoma.

  66. 巨石斑鱼(Epinephelus lanceolatus)鱼卵蛋白水解物通过凋亡和氧化应激抑制口腔癌细胞增殖

    Roe Protein Hydrolysates of Giant Grouper (Epinephelus lanceolatus) Inhibit Cell Proliferation of Oral Cancer Cells Involving Apoptosis and Oxidative Stress.

  67. 肿瘤坏死因子受体相关因子6通过促进AKT泛素化和磷酸化促进人类癌症的恶性行为

    Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation.

  68. 口腔癌进展过程中DNA甲基化变化的全局分析

    Global analysis of DNA methylation changes during progression of oral cancer.

  69. G15,一种GPR30拮抗剂,诱导人口腔鳞癌细胞凋亡和自噬

    G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells.

  70. 台湾杉素C通过ERK1/2失活选择性抑制槟榔碱和4-NQO诱导的口腔癌细胞增殖

    Taiwanin C selectively inhibits arecoline and 4-NQO-induced oral cancer cell proliferation via ERK1/2 inactivation.

  71. 准确性足够吗?临床神经生理学中基于人工智能的临床决策支持的信任与障碍

    Is accuracy enough? trust and barriers to AI-based clinical decision support in clinical neurophysiology.

  72. 基于人工智能的医疗决策支持:探索数据缺口

    AI-Based Medical Decision Support: Exploring the Data Gap.

  73. 当机器做决定:探索对人工智能的信任如何影响临床决策支持系统与护士决策后悔之间的关系:一项横断面研究

    When Machines Decide: Exploring How Trust in AI Shapes the Relationship Between Clinical Decision Support Systems and Nurses' Decision Regret: A Cross-Sectional Study.

  74. 人工智能用于危重症和外科患者的血流动力学评估:聚焦临床应用

    AI for the hemodynamic assessment of critically ill and surgical patients: focus on clinical applications.

  75. 人工智能决策支持系统在CT扫描中检测颅内出血的临床影响

    Clinical Impact of an AI Decision Support System for Detection of Intracranial Hemorrhage in CT Scans.

  76. 急诊科中基于人工智能的临床决策支持:范围综述

    Artificial intelligence-based clinical decision support in the emergency department: A scoping review.

  77. 将人工智能集成到前列腺MR成像中:技术基础、临床应用和工作流程影响

    Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.

  78. 将基于人工智能的支持系统整合到临床实践中的构想

    A Concept for Integrating AI-Based Support Systems into Clinical Practice.

  79. 人工智能支持的共享决策(AI-SDM):概念框架

    AI-Supported Shared Decision-Making (AI-SDM): Conceptual Framework.

  80. 使用生成式人工智能将冰冻切片转换为FFPE图像用于皮肤癌切除边缘

    Translation of frozen sections into FFPE images for skin cancer resection margins using generative AI.

  81. 探讨护士对以患者为中心的人工智能系统在压力伤害预防中的可接受性和准备程度

    Exploring Nurses' Acceptability and Readiness for Patient-Centered Artificial Intelligence Systems in Pressure Injury Prevention.

  82. 人工智能在胶质母细胞瘤诊疗变革中的应用

    Artificial Intelligence in Glioblastoma-Transforming Diagnosis and Treatment.

  83. 医学中的技术:改善临床文档记录

    Technology in Medicine: Improving Clinical Documentation.

  84. 人工智能和机器学习在癌症诊断中的临床应用:展望未来

    Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future.

  85. 临床中基于人工智能的决策支持系统伦理入门

    Primer on an ethics of AI-based decision support systems in the clinic.

  86. 转化中的肺细胞学

    Pulmonary Cytology in Transformation.

  87. 心理健康保健中的务实人工智能增强:一线临床医生的关键技术、潜在益处以及现实世界的挑战与解决方案

    Pragmatic AI-augmentation in mental healthcare: Key technologies, potential benefits, and real-world challenges and solutions for frontline clinicians.

  88. Dynamicasome——一种分子动力学引导和人工智能驱动的全基因突变致病性预测目录

    Dynamicasome-a molecular dynamics-guided and AI-driven pathogenicity prediction catalogue for all genetic mutations.

  89. 中国社区中一种新型基于人工智能的糖尿病视网膜病变筛查系统评估:一项真实世界研究

    Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.

  90. 临床决策支持系统认知与接受度之间的差异:人工智能用于万古霉素给药的实施

    Discrepancy between perceptions and acceptance of clinical decision support Systems: implementation of artificial intelligence for vancomycin dosing.

  91. 术前计划的技术进步

    Technological Advances in Pre-Operative Planning.

  92. [基于人工智能的胸部X线判读检测辅助设备的临床应用:现状与实践考量]

    [Clinical Application of Artificial Intelligence-Based Detection Assistance Devices for Chest X-Ray Interpretation: Current Status and Practical Considerations].

  93. 人工智能与机器学习在重建显微外科中的应用

    Artificial Intelligence and Machine Learning in Reconstructive Microsurgery.

  94. 医疗保健中人工智能的开放科学方法

    An Open Science Approach to Artificial Intelligence in Healthcare.

  95. 编辑评论:审慎应用人工智能技术可提高诊断准确性并支持临床决策

    Editorial Commentary: Thoughtful Application of Artificial Intelligence Technique Improves Diagnostic Accuracy and Supportive Clinical Decision-Making.

  96. 基于人工智能的决策支持改善头颈部放疗计划质量的前瞻性研究

    Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality.

  97. 基于人工智能的超声成像技术用于肝脏疾病

    Artificial intelligence-based ultrasound imaging technologies for hepatic diseases.

  98. 用于癌症检测的可解释深度学习:人工智能架构和可解释性分析的融合

    Interpretable deep learning for gastric cancer detection: a fusion of AI architectures and explainability analysis.

  99. 推动人工智能用于全球成年女性乳腺癌风险预测和筛查:一项范围综述

    Promoting Artificial Intelligence for Global Breast Cancer Risk Prediction and Screening in Adult Women: A Scoping Review.

  100. 探索医生对结直肠癌精准医学和人工智能的看法:医患关系的机遇与挑战

    Exploring doctors' perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship.

  101. 使用内漏风险指数进行基于人工智能的EVAR规划的早期临床经验支持其在个体化决策和教育中的价值

    Early clinical experiences with AI-based EVAR planning using the Endoleak Risk Index support its value for individualized decision-making and education.

  102. 通过与放射学指南对齐的语言模型评估真实世界患者病例的急性影像检查申请

    Evaluating acute image ordering for real-world patient cases via language model alignment with radiological guidelines.

  103. ARTEMIS:一项在模拟神经内分泌肿瘤临床病例中比较基于人工智能与专家治疗决策的初步研究

    ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms.

  104. 人工智能如何改变肾脏病学

    How artificial intelligence is transforming nephrology.

  105. 一个用于人工智能辅助反应适应性放疗决策的临床决策支持系统(ARCliDS)

    A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS).

  106. 提供照护:内在人机团队与数据

    Providing Care: Intrinsic Human-Machine Teams and Data.

  107. 文献计量分析证实了消费者健康信息出版物的预期趋势

    Bibliometric analysis confirms expected trends in consumer health information publications.

  108. 废物管理与绿色技术研究成果的映射与可视化:文献计量学综述

    Mapping and visualizing of research output on waste management and green technology: A bibliometric review of literature.

  109. 糖尿病肾病足细胞损伤机制的研究:2000年至2024年的文献计量和知识图谱分析

    Research on podocyte injury mechanisms in diabetic nephropathy: a bibliometric and knowledge-map analysis from 2000 to 2024.

  110. 土地利用对溪流大型无脊椎动物的影响:2010-2021年文献计量分析

    The impact of land use on stream macroinvertebrates: a bibliometric analysis for 2010-2021.

  111. 缺血性卒中炎症和线粒体应激的文献计量学见解

    Bibliometric insights into the inflammation and mitochondrial stress in ischemic stroke.

  112. 近二十年斑秃治疗的文献计量学

    A Bibliometrics of the Treatment of Alopecia Areata in the Past Twenty Years.

  113. 用于解码病理生理学中细胞进化的谱系追踪技术:文献计量分析

    Lineage-tracing technology for decoding cell evolution in pathophysiology: a bibliometric analysis.

  114. 斋月间歇性禁食研究七十年:文献计量学分析、全球趋势与未来方向

    Seven decades of Ramadan intermittent fasting research: Bibliometrics analysis, global trends, and future directions.

  115. 2002年至2021年幽门螺杆菌研究的状态与热点:文献计量分析

    States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis.

  116. 他汀类药物使用与痴呆之间的关联及相关机制:2007年至2023年的文献计量分析

    Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023.

  117. 铁中毒与免疫:研究热点和前沿的文献计量分析(2012-2025)

    Ferroptosis and immunity: a bibliometric analysis of research hotspots and frontiers (2012-2025).

  118. IL-37的知识基础与研究前沿:基于WoSCC文献的文献计量学综述

    The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC.

  119. 健康研究领域具有影响力的期刊:一项文献计量学研究

    Influential journals in health research: a bibliometric study.

  120. 如何评价科学产出

    HOW TO EVALUATE SCIENTIFIC PRODUCTION.

  121. 基于电穿孔的癌症治疗应用的研究前沿:文献计量分析

    Research frontiers of electroporation-based applications in cancer treatment: a bibliometric analysis.

  122. 重症肌无力发展全球趋势的知识图谱:文献计量学分析

    Knowledge mapping of global trends for myasthenia gravis development: A bibliometrics analysis.

  123. 子痫前期中外泌体的知识图谱:文献计量分析(2008-2023年)

    Knowledge mapping of exosomes in preeclampsia: a bibliometric analysis (2008-2023).

  124. 输尿管支架(1975年至今)的可视化文献计量全景:趋势与热点揭示

    Visualized bibliometric panorama of ureteral stents (1975-present): trends and hotspots revealed.

  125. 计算机辅助分子设计期刊:文献计量学注释

    The Journal of Computer-Aided Molecular Design: a bibliometric note.

  126. 骨质疏松症中巨噬细胞的知识图谱:文献计量分析(1999-2023)

    Knowledge Mapping of Macrophages in Osteoporosis: A Bibliometric Analysis (1999-2023).

  127. 运动训练与慢性肾脏病:临床干预试验 citation classics 的特征与文献计量学分析

    Exercise training and chronic kidney disease: characterization and bibliometrics of citation classics of clinical intervention trials.

  128. 拉丁美洲减重手术研究:文献计量学研究

    Latin American Research on Bariatric Surgery: a Bibliometric Study.

  129. 过去五年生物医学科学中人工智能主题区域发表趋势的差异:文献计量学分析

    Disparities in Regional Publication Trends on the Topic of Artificial Intelligence in Biomedical Science Over the Last Five Years: A Bibliometric Analysis.

  130. [噪声性听力损失易感性遗传文献的文献计量学和生物信息学分析]

    [Bibliometric and bioinformatics analysis of genetic literature on susceptibility to noise induced hearing loss].

  131. [对“关于文章‘墨西哥社会保障研究所工作人员撰写的COVID-19科学出版物文献计量学分析’的评论”的回复]

    [Aswer to "Comment on article "Bibliometric analysis of scientific publications on COVID-19 elaborated by staff of the Instituto Mexicano del Seguro Social""].

  132. 基于CiteSpace和VOSviewer的心房颤动与衰弱研究的文献计量学分析

    Bibliometric analysis of atrial fibrillation and frailty research based on CiteSpace and VOSviewer.

  133. 唇裂和腭裂领域50篇最高被引论文的文献计量学分析

    A bibliometric analysis of the 50 most cited papers in cleft lip and palate.

  134. 血清淀粉样蛋白A在感染中的研究现状:文献计量学分析

    Research status of serum amyloid A in infection: a bibliometric analysis.

  135. 纺织废水处理:知识图谱映射分析

    Textile waste water treatment: analysis of mapping knowledge domains.

  136. [1997年至2001年《中国医疗器械杂志》科技论文学术计量分析]

    [Bibliometric analysis of scientific papers of "Chinese Journal of Medical Instrumentation" from 1997 to 2001].

  137. 视神经脊髓炎谱系障碍治疗的研究热点和新兴课题:来自文献计量分析的见解

    Research hotspots and emerging topics in neuromyelitis optica spectrum disorder treatment: Insights from a bibliometric analysis.

  138. 文献计量学:研究学术出版的方法

    Bibliometrics: Methods for studying academic publishing.

  139. 1980年至2016年补充医学文献中蜂疗的文献计量学分析

    Bibliometric analysis of apitherapy in complementary medicine literature between 1980 and 2016.

  140. 成釉细胞瘤被引最多的100篇文章分析

    Analysis of the 100 most cited articles on ameloblastoma.

  141. N6甲基腺苷(m6A)在炎症中的修饰:文献计量分析和文献综述

    N6-methyladenosine (m6A) modification in inflammation: a bibliometric analysis and literature review.

  142. 护理教学中的灵性:文献计量学分析

    Teaching Spirituality in Nursing: A Bibliometric Analysis.

  143. 透析患者衰弱的文献计量学分析:知识映射与趋势

    Bibliometric analysis of frailty in dialysis patients: knowledge mapping and trends.

  144. 心脏外科远程缺血预处理的新趋势和研究热点:文献计量分析

    Emerging Trends and Research Hotspots of Remote Ischemic Preconditioning in Cardiac Surgery: A Bibliometric Analysis.

  145. 肌少症营养研究趋势:文献计量学分析

    Trends in Nutrition Research for Sarcopenia: A Bibliometric Analysis.

  146. 个人防护装备与新冠肺炎研究的文献计量分析

    A Bibliometric Analysis of Personal Protective Equipment and COVID-19 Researches.

  147. 免疫相关不良事件:文献计量分析

    Immune-related adverse events: A bibliometric analysis.

  148. [非酒精性脂肪肝的饮食建议]

    [Dietetary recommendation for non-alcoholic fatty liver disease].

  149. 非酒精性脂肪性肝病中潜在的表观遗传学机制

    Potential epigenetic mechanism in non-alcoholic Fatty liver disease.

  150. 非酒精性脂肪肝(NAFLD)进展中的肠道微生物组分和代谢产物

    Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).

  151. 识别非酒精性脂肪性肝病侵袭性疾病表型的新判别方法

    New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease.

  152. 非酒精性脂肪性肝病的诊断与治疗

    The diagnosis and treatment of non-alcoholic fatty liver disease.

  153. [非酒精性脂肪性肝病诊治进展]

    [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].

  154. 黄酮类化合物治疗非酒精性脂肪肝的潜力

    The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.

  155. 自噬失调在非酒精性脂肪性肝病进展中的关键作用

    The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease.

  156. 双酚A通过促进NLRP3的O-GlcNAc糖基化诱导非酒精性脂肪性肝病

    Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3.

  157. C肽作为美国人群非酒精性脂肪性肝病的关键危险因素

    C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.

  158. 非酒精性脂肪肝(NAFLD)发病机制和预防和治疗的天然产品

    Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.

  159. 小檗碱治疗非酒精性脂肪肝的潜在机制

    The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.

  160. 非酒精性脂肪性肝病(NAFLD)纤维化评分可预测中国NAFLD患者6.6年总体死亡率

    Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD.

  161. 伴与不伴代谢综合征的非酒精性脂肪性肝病:不同的长期结局

    Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.

  162. 血清非靶向代谢组学揭示非酒精性脂肪性肝病不同亚型的代谢状态

    Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease.

  163. 药物发现中的非酒精性脂肪肝(NAFLD)模型

    Non-alcoholic fatty liver disease (NAFLD) models in drug discovery.

  164. 高心代谢风险个体的等热量饮食变化和非酒精性脂肪肝

    Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.

  165. 非酒精性脂肪肝的诊断和治疗

    Diagnosis and management of non-alcoholic fatty liver disease.

  166. 饮食因素与肝脏脂肪含量的关系:一项横断面研究

    Dietary Factors in Relation to Liver Fat Content: A Cross-sectional Study.

  167. 非酒精性脂肪性肝病作为心力衰竭的新兴危险因素

    Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure.

  168. 美国人群中膳食钠摄入与非酒精性脂肪性肝病之间的关联

    Association between dietary sodium intake and non-alcoholic fatty liver disease in the US population.

  169. 免疫反应作为非酒精性脂肪性肝病的治疗靶点

    The immune response as a therapeutic target in non-alcoholic fatty liver disease.

  170. 非酒精性脂肪性肝病中的细胞骨架改变

    Cytoskeleton alterations in non-alcoholic fatty liver disease.

  171. 饮食、肠道菌群与非酒精性脂肪性肝病:同一轴线的三个组成部分

    Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis.

  172. 澳大利亚非酒精性脂肪性肝病负担:1990年至2019年全球疾病负担研究的分析

    The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019.

  173. 血清miR-29a和miR-122作为非酒精性脂肪性肝病(NAFLD)的潜在生物标志物

    Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD).

  174. {"_":"基因中的遗传多态性,TLR4的共受体,与非酒精性脂肪性肝病相关。","i":["CD14"]}

    {"_":"Genetic polymorphism in gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease.","i":["CD14"]}

  175. 代谢性脂肪肝和酒精性脂肪肝的实验模型

    Experimental models of metabolic and alcoholic fatty liver disease.

  176. 人工智能(AI)在非酒精性脂肪肝(NAFLD)研究中的应用:系统综述

    Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review.

  177. 与匹配的对照组相比,发生心血管事件后的NAFLD女性患者他汀类药物使用不足

    Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects.

  178. 无代谢综合征的重度肥胖受试者中经活检证实的非酒精性脂肪性肝病患病率

    Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.

  179. 急性冠脉综合征合并非酒精性脂肪性肝病患者内皮功能障碍的生物标志物诊断

    Biomarker diagnostics of endothelial dysfunction in patients with acute coronary syndrome and non-alcoholic fatty liver disease.

  180. 固有免疫信号在非酒精性脂肪性肝病中的作用

    Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease.

  181. 确定NAFLD治疗靶点的人类遗传学:挑战和机遇

    Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities.

  182. 在2型糖尿病患者中,非肥胖型NAFLD的心血管代谢风险特征并不优于肥胖型NAFLD

    Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients.

  183. 非酒精性脂肪性肝病与动脉粥样硬化关系的研究进展

    Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.

  184. NAFLD的演变及其管理

    Evolution of NAFLD and Its Management.

  185. 非酒精性脂肪性肝病中的生物标志物——皇帝没穿衣服?

    Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?

  186. 非酒精性脂肪性肝病的发病机制及相关治疗策略

    Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease.

  187. [NF-κB在非酒精性脂肪肝发病过程中的作用]

    [Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease].

  188. 肝脏脂肪变性:第三个千年的新流行病。良性肝脏状态还是沉默的杀手?

    Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer?

  189. AMPK在MASLD发病机制和治疗中的研究进展

    Research progress on AMPK in the pathogenesis and treatment of MASLD.

  190. 胆汁酸调节:非酒精性脂肪性肝病的一种新型治疗策略

    Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease.

  191. 关于脂肪细胞因子在非酒精性脂肪性肝病发病机制中的作用及其与肝细胞因子关联的最新研究进展

    Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.

  192. 非酒精性脂肪肝和2型糖尿病:常见的病理生理机制

    Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.

  193. 在实验小鼠中模拟进行性非酒精性脂肪性肝病

    Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.

  194. 载脂蛋白A5基因多态性与非酒精性脂肪性肝病相关

    Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.

  195. 白蛋白校正阴离子间隙与非酒精性脂肪性肝病的关系在不同腰围组中有所不同:一项横断面研究

    Relationship between albumin-corrected anion gap and non-alcoholic fatty liver disease varied in different waist circumference groups: a cross-sectional study.

  196. 肥胖和非酒精性脂肪肝:从病理生理学到治疗学

    Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

  197. 管理医疗保健中的财务风险:中国的医疗费用焦虑、金融创新与收入流动性

    Managing financial risk in healthcare: Medical cost anxiety, financial innovation, and income mobility in China.

  198. “7mind”应用程序作为预防低风险样本组产后抑郁干预措施的效果

    Efficacy of the "7mind"-app as intervention to prevent postpartum depression in a low-risk sample group.

  199. 范围综述:虚拟现实如何被用作支持磁共振成像检查体验的工具?

    Scoping review: How is virtual reality being used as a tool to support the experience of undergoing Magnetic resonance imaging?

  200. 对外貌差异与恋爱关系的理解与体验:一项质性探索

    Understandings and experiences of visible difference and romantic relationships: A qualitative exploration.

  201. 埃及地中海贫血患者焦虑和抑郁的预测因素:一项si... (原文已截断)

    Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study.

  202. 挪威16岁代表性人群中牙科恐惧症的患病率及共病情况

    Prevalence and Comorbidity of Dental Phobia in a Representative Population of 16-Year-Olds in Norway.

  203. 在新冠肺炎期间修改夏季本科生研究项目增加了研究生院的意向,但加剧了焦虑

    Modifying Summer Undergraduate Research Programs during COVID-19 Increased Graduate School Intentions but Exacerbated Anxieties.

  204. 心理健康报告中的压力偏倚:死亡焦虑偏倚了部署士兵的心理健康自我评估

    The stress bias in mental health reporting: Death anxiety biases mental health self-assessments amongst deployed soldiers.

  205. 围手术期洛索洛芬钠与牙种植手术中较低疼痛和焦虑水平相关:一项中国队列研究

    Perioperative loxoprofen sodium is associated with lower pain and anxiety levels in dental implant surgery: a cohort study in China.

  206. 妊娠相关焦虑量表的初步开发

    The initial development of the Pregnancy-related Anxiety Scale.

  207. COVID-19阳性患者隔离后的焦虑和抑郁水平——北塞浦路斯

    Post-quarantine anxiety and depression levels of COVID-19 positive patients, Northern Cyprus.

  208. 社会压力指标(SSI)

    The Social Stress Indicator (SSI).

  209. 医学生对临床培训的焦虑

    The anxieties of medical students related to clinical training.

  210. 日本成人先天性心脏病患者的社会独立性

    Social independence of adult congenital heart disease patients in Japan.

  211. 精神分析在跨性别儿童和青少年问题上是否已触及极限?

    Has Psychoanalysis Reached Its Limits in the Question of the Trans Child and Adolescent?

  212. 中枢阿片能神经系统对焦虑情绪状态的调节及其可能机制

    [Regulation of the central opioidergic nervous system on the emotional state of anxiety and its possible mechanisms].

  213. 早期妊娠丢失后的再次妊娠:焦虑、抑郁症状及应对方式的前瞻性研究

    Pregnancy after early pregnancy loss: a prospective study of anxiety, depressive symptomatology and coping.

  214. 新加坡学龄儿童自我报告的抑郁和焦虑症状

    Self-reported depression and anxiety symptoms in school-aged Singaporean children.

  215. 分析师在慢性危机时期对精神分析治疗的作用

    The role of the analyst in the analytic cure during times of chronic crises.

  216. 年龄歧视研究的下一个关键转向:年龄歧视与体能歧视的交织

    The Next Critical Turn for Ageism Research: The Intersections of Ageism and Ableism.

  217. 东方草药柴朴汤对组胺能诱导的小鼠焦虑的类抗焦虑作用

    Anxiolytic-like effect of saiboku-to, an oriental herbal medicine, on histaminergics-induced anxiety in mice.

  218. 湿滑难行:不完美的解释艺术

    Slippery when wet: the imperfect art of interpretation.

  219. [过敏性鼻炎对状态-特质焦虑的影响]

    [The impact of allergic rhinitis on state-trait anxiety].

  220. <编辑精选>使用文本挖掘开发在线讲座可减少COVID-19非震中地区卫生工作者的焦虑

    <Editors' Choice> Developing online lectures using text mining reduces health workers' anxiety in non-epicenter areas of COVID-19.

  221. 儿童数字媒体、焦虑与抑郁

    Digital Media, Anxiety, and Depression in Children.

  222. 女教师的数学焦虑影响女生的数学成绩

    Female teachers' math anxiety affects girls' math achievement.

  223. 乳腺癌焦虑与化学预防决策辅助工具反应之间的关联

    Breast cancer anxiety's associations with responses to a chemoprevention decision aid.

  224. 应对资源和自尊对创伤性脑损伤后威胁评估与活动回避之间关系的调节作用评估

    Evaluation of coping resources and self-esteem as moderators of the relationship between threat appraisals and avoidance of activities after traumatic brain injury.

  225. 家庭特征对牙科恐惧的影响:一项横断面研究

    Effects of Familial Characteristics on Dental Fear: A Cross-sectional Study.

  226. 妊娠期睡眠质量与产后焦虑的关系:一项前瞻性出生队列研究

    Relationship between sleep quality during pregnancy and postpartum anxiety: a prospective birth cohort study.

  227. COVID-19疫苗焦虑:探索塞拉利昂科诺区疫苗态度的社会和政治驱动因素

    COVID-19 vaccine anxieties: exploring social and political drivers of vaccine attitudes in Kono District, Sierra Leone.

  228. 积极性观念在孟加拉国未婚青少年性健康项目中的重要性

    The importance of a positive approach to sexuality in sexual health programmes for unmarried adolescents in Bangladesh.

  229. SARS-CoV-2疫情期间德国教师的心理负担——来自全国横断面在线调查的亚组分析

    Psychological Burdens among Teachers in Germany during the SARS-CoV-2 Pandemic-Subgroup Analysis from a Nationwide Cross-Sectional Online Survey.

  230. 体育旅游中的内心对话与营养焦虑:理解跑者在国外赛前食物相关压力中的习惯

    Inner Dialogues and Nutritional Anxiety in Sports Tourism: Understanding Runners' Habits in Pre-Race Food-Related Stress Abroad.

  231. “我们的一大国病”:世纪之交的神经衰弱与美国帝国及男性焦虑

    "Our one great national malady": Neurasthenia and American Imperial and Masculine Anxiety at the Turn of the Twentieth Century.

  232. COVID-19疫情期间新手父母的痛苦与忧虑:个人资源的作用

    Distress and apprehension among new parents during the COVID-19 pandemic: The contribution of personal resources.

  233. 父母照顾有学习障碍和程序性焦虑的住院儿童的经历:一项解释性现象学研究

    Parental experiences of caring for children who have learning disabilities and procedural anxiety in hospital: An interpretive phenomenological study.

  234. 焦虑与表现:持续心理压力下前额叶亚区的不同作用

    Anxiety and performance: the disparate roles of prefrontal subregions under maintained psychological stress.

  235. 支持患有抑郁和焦虑的虚弱老年人:一项定性研究

    Supporting frail older people with depression and anxiety: a qualitative study.

  236. 讲故事对癌症患儿焦虑水平的影响:单组前测-后测研究

    The Effect of Storytelling on Anxiety Level of Children With Cancer: One-Group Pretest-Posttest Study.

  237. 约翰·鲍尔比在塔维斯托克

    John bowlby at the Tavistock.

  238. 基督城地震:前难民如何应对?

    Christchurch earthquakes: how did former refugees cope?

  239. 使用植入前遗传学诊断的夫妇中的抑郁、妊娠相关焦虑和父母-产前依恋

    Depression, pregnancy-related anxiety and parental-antenatal attachment in couples using preimplantation genetic diagnosis.

  240. Pit-a-Pat:一种用于检测心律失常的智能心电图系统

    Pit-a-Pat: A Smart Electrocardiogram System for Detecting Arrhythmia.

  241. 从单导联心电信号生成的多导联心电信号分类可行性测试

    Classification feasibility test on multi-lead electrocardiography signals generated from single-lead electrocardiography signals.

  242. 马心电图学

    Equine Electrocardiography.

  243. 压缩心电生物特征:一种快速、安全且高效的心血管疾病患者识别方法

    Compressed ECG biometric: a fast, secured and efficient method for identification of CVD patient.

  244. 心电图技术与技术

    ECG techniques and technologies.

  245. 医院环境中心电监护的实践标准:执行摘要和实施指南

    Practice standards for ECG monitoring in hospital settings: executive summary and guide for implementation.

  246. PTB-XL+,一个综合性的心电图特征数据集

    PTB-XL+, a comprehensive electrocardiographic feature dataset.

  247. 基于系数对齐的有效心电图隐写术

    Effective Electrocardiogram Steganography Based on Coefficient Alignment.

  248. 用于动态心脏监护的体动活动识别

    Body movement activity recognition for ambulatory cardiac monitoring.

  249. 心脏再同步化治疗的心电图学:陷阱与实用技巧

    Electrocardiography of cardiac resynchronization therapy: Pitfalls and practical tips.

  250. 用于长期监测的非接触式可穿戴无线心电图系统

    Noncontact Wearable Wireless ECG Systems for Long-Term Monitoring.

  251. 12导联心电图基础

    Basics of the 12-lead ECG.

  252. 运动员心电图学:正常与异常表现

    Electrocardiography in athletes: normal and abnormal findings.

  253. 塞巴短尾蝠(Carollia perspicillata)的心电图信号

    The electrocardiogram signal of Seba's short-tailed bat, Carollia perspicillata.

  254. 心电图和超声心动图中的机器学习:临床心脏病学的技术进步

    Machine Learning in Electrocardiography and Echocardiography: Technological Advances in Clinical Cardiology.

  255. 标准和Lewis心电图在检测宽QRS波心动过速患者房室分离中的比较

    Comparison of standard and Lewis ECG in detection of atrioventricular dissociation in patients with wide QRS tachycardia.

  256. 用于超声小动物成像的心电图触发与门控

    ECG triggering and gating for ultrasonic small animal imaging.

  257. 改良心前导联心电图SafOne在心电图记录中的应用

    Modified precordial lead ECG SafOne on electrocardiography recordings.

  258. 一种基于紧凑型平面时尚电路板衬衫的可穿戴心电采集系统

    A wearable ECG acquisition system with compact planar-fashionable circuit board-based shirt.

  259. 睡眠心电与体位监测系统

    Sleeping ECG and body position monitoring system.

  260. 心电图焦虑特征改善言语焦虑

    Electrocardiographic anxiety profiles improve speech anxiety.

  261. 心电图困境:改善判读的指南

    The ECG dilemma: guidelines on improving interpretation.

  262. 一种用于远程心电图的医疗级无线架构

    A medical-grade wireless architecture for remote electrocardiography.

  263. 一种用于连续全面监测心血管系统的织物腕部贴片传感器

    A fabric wrist patch sensor for continuous and comprehensive monitoring of the cardiovascular system.

  264. 频谱-时间映射在检测犬心室晚电位中的失败

    Failure of spectro-temporal mapping to detect ventricular late potentials in dogs.

  265. 院前12导联心电图诊断方案

    Prehospital 12-lead ECG diagnostic programs.

  266. ICU护士心电图判读的实践与信心:一项横断面研究

    Practice and confidence in electrocardiogram interpretation among ICU nurses: A cross-sectional study.

  267. 改进Brugada心电图模式诊断的方法

    Methods for Improving the Diagnosis of a Brugada ECG Pattern.

  268. 基于心电信号语义分割的房室传导阻滞自动分类

    Automated Classification of Atrioventricular Block Based on Semantic Segmentation of ECG Signals.

  269. 从两个皮下ICD向量重建8导联体表心电图

    Reconstruction of an 8-lead surface ECG from two subcutaneous ICD vectors.

  270. 过敏性鼻炎:不仅仅是鼻塞

    Allergic rhinitis: more than just a stuffy nose.

  271. 比利时过敏性和非过敏性鼻炎的患病率、分类和认知

    Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium.

  272. 变应性和非变应性鼻炎的病理生理学

    Pathophysiology of allergic and nonallergic rhinitis.

  273. 过敏性鼻炎和慢性鼻窦炎:它们对下呼吸道的影响

    Allergic rhinitis and chronic rhinosinusitis: their impact on lower airways.

  274. 过敏性鼻炎临床试验中皮下免疫治疗和舌下免疫治疗结局的可比性

    Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.

  275. 用位置性鼻阻力测量法诊断鼻高反应性

    Diagnosing nasal hyperreactivity with positional rhinomanometry.

  276. 儿童过敏性鼻炎和哮喘诊断与治疗的最新进展

    Recent advances in diagnosis and therapy of allergic rhinitis and asthma in childhood.

  277. 老年过敏性鼻炎患者的临床和细胞学特征

    Clinical and cytologic characteristics of allergic rhinitis in elderly patients.

  278. 过敏性鼻炎与哮喘之间的联系:抗白三烯药物是否有作用?

    The link between allergic rhinitis and asthma: a role for antileukotrienes?

  279. 过敏性和非过敏性鼻炎中的鼻高反应性:非特异性建筑相关疾病的潜在危险因素

    Nasal hyperreactivity in allergic and non-allergic rhinitis: a potential risk factor for non-specific building-related illness.

  280. 持续性鼻炎-过敏性还是非过敏性?

    Persistent rhinitis - allergic or nonallergic?

  281. 过敏性鼻炎对睡眠的影响

    Influences of allergic rhinitis on sleep.

  282. [鼻息肉病和过敏性鼻炎——我们的经验]

    [Nasal polyposis and allergic rhinitis--our experience].

  283. 变应性鼻炎及其对哮喘的影响(ARIA 2008)。比利时视角

    Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective.

  284. [过敏性鼻炎——21世纪的流行病学、经济和社会问题]

    [Allergic rhinitis--an epidemiological, economical and social problem of the XXI century].

  285. 间歇性和持续性过敏性鼻炎的特征:DREAMS研究组

    Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group.

  286. [真菌过敏原致敏豚鼠过敏性鼻炎鼻黏膜中eotaxin基因的表达]

    [Expression of eotaxin gene in nasal mucosa of allergic rhinitis in the guinea pig sensitized by fungal allergen].

  287. [非哮喘患者由草花粉引起的下呼吸道过敏反应]

    [Allergic reaction of the lower airways of non asthmatic patients caused by grass pollen].

  288. 变应性鼻炎和哮喘共病

    Allergic rhinitis and asthma co-morbidity.

  289. 过敏性鼻炎:疾病、现有治疗和未来前景的最新进展

    Allergic rhinitis: an update on disease, present treatments and future prospects.

  290. 变应性鼻炎及其对哮喘的影响更新(ARIA 2008)。西班牙的视角

    Allergic Rhinitis and its Impact on Asthma update (ARIA 2008). The perspective from Spain.

  291. 过敏性鼻炎:更广泛的疾病影响及其对管理的意义

    Allergic rhinitis: broader disease effects and implications for management.

  292. [变应性鼻炎]

    [Allergic rhinitis].

  293. 变应性鼻炎及其对哮喘的影响:变应性鼻炎的循证治疗策略

    Allergic rhinitis and its impact on asthma: an evidence-based treatment strategy for allergic rhinitis.

  294. 过敏性鼻炎与学业成绩

    Allergic rhinitis and school performance.

  295. [鼻炎与过敏性哮喘的关系。抗组胺药对支气管高反应性的作用]

    [The relation between rhinitis and allergic asthma. The action of antihistaminics on bronchial hyperreactivity].

  296. 过敏性鼻炎和哮喘的负担

    The burden of allergic rhinitis and asthma.

  297. 过敏性鼻炎和哮喘中的鼻-肺相互作用:联合气道疾病

    The nose-lung interaction in allergic rhinitis and asthma: united airways disease.

  298. 过敏性和非过敏性鼻炎:与鼻息肉病、哮喘和家族史的关系

    Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history.

  299. [当前实践中如何管理变应性鼻炎]

    [How to manage allergic rhinitis in current practice].

  300. 过敏性鼻炎的发病机制

    Pathogenesis of allergic rhinitis.

  301. [代尼兹利成人城市人口中变应性鼻炎的患病率]

    [The prevalence of allergic rhinitis in the adult urban population of Denizli].

  302. 长效β(2)受体激动剂在哮喘和过敏性鼻炎中的应用

    Long-acting beta(2) agonists in asthma and allergic rhinitis.

  303. 过敏性鼻炎:过去、现在与未来

    Allergic rhinitis: past, present and the future.

  304. 过敏性鼻炎的经济影响和生活质量负担

    Economic impact and quality-of-life burden of allergic rhinitis.

  305. 过敏性鼻炎的系统免疫学和炎症方面

    Systemic immunologic and inflammatory aspects of allergic rhinitis.

  306. 过敏性鼻炎:流行病学、诊断和治疗

    Allergic rhinitis: epidemiological aspects, diagnosis and treatment.

  307. [常年性过敏性和季节性过敏性鼻炎患者听觉器官的评估]

    [Assessment of the hearing organ in the patients with allergic perennial and seasonal allergic rhinitis].

  308. [北海道上士幌町成人哮喘和过敏性鼻炎的患病率——与吸烟习惯和肥胖的关系]

    [Prevalence of adult asthma and allergic rhinitis in Kamishihoro town, Hokkaido--association with smoking habit and obesity].

  309. 变应性鼻炎的流行病学

    Epidemiology of allergic rhinitis.

  310. 皮下免疫治疗

    Subcutaneous immunotherapy.

  311. 胶质母细胞瘤的核医学成像技术

    Nuclear Medicine Imaging Techniques in Glioblastomas.

  312. 儿童核医学检查的准备:一种按时间顺序、多模式的非镇静护理方法

    Preparation of children for nuclear medicine examinations: A chronological, multi-modal approach to sedationless care.

  313. {"_":"使用径向分布函数计算发射体的细胞交叉吸收剂量:与参考方法的比较及F-FDG细胞标记的应用。","i":["β"],"sup":["18"]}

    {"_":"Using radial distribution functions to calculate cellular cross-absorbed dose foremitters: comparison with reference methods and application forF-FDG cell labeling.","i":["β"],"sup":["18"]}

  314. 处理诊断用放射性核素的核医学工作者的眼器官剂量评估

    OCULAR ORGAN DOSE ASSESSMENT OF NUCLEAR MEDICINE WORKERS HANDLING DIAGNOSTIC RADIONUCLIDES.

  315. SNMMI和EANM成人肾闪烁显像实践指南

    The SNMMI and EANM practice guideline for renal scintigraphy in adults.

  316. 利尿剂肾闪烁显像:实践现状及标准化的潜在机遇

    Diuretic Renal Scintigraphy: The State of Practice and a Potential Opportunity for Standardization.

  317. 使用放射性标记的生长抑素受体配体诊断和治疗脑膜瘤的联合EANM/EANO/RANO/SNMMI实践指南/程序标准:1.0版

    Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.

  318. 核医学中的经济学评价研究:标准化的必要性

    Economic evaluation studies in nuclear medicine: the need for standardization.

  319. 面向核医学应用的钪放射性同位素配合物临床开发:螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)及其类似物的鼓舞人心的前景

    Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.

  320. 核医学中的历史影像:1976年:临床核医学创刊号与首次人体FDG研究

    Historic images in nuclear medicine: 1976: the first issue of clinical nuclear medicine and the first human FDG study.

  321. 重症监护病房中的床旁核医学检查

    Bedside nuclear medicine investigations in the intensive care unit.

  322. 在儿科核医学中尽量减少和传达辐射风险

    Minimizing and communicating radiation risk in pediatric nuclear medicine.

  323. 暂停水平简介:核医学

    Introduction to suspension levels: nuclear medicine.

  324. 以186Re标记脂质体多柔比星联合射频消融的放化核素治疗在裸大鼠肿瘤异种移植模型中有效治疗头颈癌

    Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.

  325. 英国核医学和PET成人诊断参考水平的解读与实施

    Interpretation and implementation of adult diagnostic reference levels in nuclear medicine and PET in the UK.

  326. 核医学:从光子到生理学

    Nuclear medicine: from photons to physiology.

  327. 马骨显像,第1部分:建立马核医学设施

    Equine Bone Imaging, Part 1: Establishing an Equine Nuclear Medicine Facility.

  328. 核医学中的诊疗一体化及纳米诊疗一体化探针

    Theranostic and nanotheranostic probes in nuclear medicine.

  329. 护士对数字化的态度和准备情况

    Attitudes and readiness of nurses towards digitalisation.

  330. 数字技术应用对企业国际化的影响:决策权集中化与国际化经验的共同调节效应

    Digital technology application on corporate internationalization: Co-moderating effect of centralizing decision power and internationalization experience.

  331. 结合数字技术与传统原则优化全口可摘义齿治疗

    Combining Digital Technology and Traditional Principles to Optimize Complete Removable Denture Treatment.

  332. 健康技术进步带来重大责任——使用数字健康技术的伦理与安全考量:叙述性综述

    With advancement in health technology comes great responsibility - Ethical and safety considerations for using digital health technology: A narrative review.

  333. 数字技术应用和供应链管理对企业循环经济的影响:动态能力观

    The effects of digital technology application and supply chain management on corporate circular economy: A dynamic capability view.

  334. 数字技术、健康与福祉及新冠大流行:是时候将非正式照护者从队伍后面请到前面了

    Digital Technology, Health and Well-Being and the Covid-19 Pandemic: It's Time to Call Forward Informal Carers from the Back of the Queue.

  335. 执业注册护士与注册实用护士的个人数字技术使用情况

    Personal digital technology use among practicing Registered Nurses and Registered Practical Nurses.

  336. 错失恐惧、数字技术使用与心理健康之间的关系:概念与实证问题的范围综述

    The relationship between fear of missing out, digital technology use, and psychological well-being: A scoping review of conceptual and empirical issues.

  337. 数字技术在姑息治疗中的应用范围综述

    A scoping review of digital technology applications in palliative care.

  338. 评估中国青少年数字技术使用与身体健康、体能及锻炼水平之间的关系:父母监控的调节效应

    Assessing the relationship between digital technology use and physical health, fitness, and exercise levels among Chinese youth: The moderating effect of parental monitoring.

  339. 数字技术在认知衰退中的应用:文献计量与可视化研究

    Digital Technology in Cognitive Decline: Bibliometric and Visualization Study.

  340. 高管信息技术背景与企业数字技术创新:来自中国微型企业的证据

    Executives' IT background and corporate digital technology innovation: Evidence from Chinese microenterprises.

  341. 在临床试验中使用数字技术:当前和未来的应用

    Using digital technologies in clinical trials: Current and future applications.

  342. 数字技术作为护生协作工具的使用——调查研究与验证

    Use of Digital Technology as a Collaborative Tool among Nursing Students-Survey Study and Validation.

  343. 使用数字技术自我监测饮食和体力活动行为能否支持肥胖或超重成年人减重?一项带荟萃分析的系统文献综述

    Does self-monitoring diet and physical activity behaviors using digital technology support adults with obesity or overweight to lose weight? A systematic literature review with meta-analysis.

  344. 针对数字技术问题性使用的治疗干预:系统综述与证据荟萃分析

    Therapeutic Interventions Targeted at Problematic Use of Digital Technology: Systematic Review and Meta-Analysis of Evidence.

  345. 数字技术使用及其与儿童学习和社会交往的关联:纵向研究方法

    Digital technology use and associations with children's learning and social interaction: A longitudinal approach.

  346. 东部地中海区域在COVID-19疫情期间利用数字技术提供非传染性疾病服务的经验与教训

    Experiences and lessons from using digital technology for noncommunicable disease services during the COVID-19 pandemic in the Eastern Mediterranean Region.

  347. 使用数字技术进行吞咽障碍康复:范围综述

    Dysphagia Rehabilitation Using Digital Technology: A Scoping Review.

  348. 数字-产业技术融合能否降低企业碳排放?

    Does digital-industrial technology integration reduce corporate carbon emissions?

  349. 分析数字技术采用对优质农民生产经营收入的影响

    An analysis of the impact of digital technology adoption on the income of high quality farmers in production and operating.

  350. 利用虚拟医院教育资源向本科生提供数字健康教育

    Delivering Digital Health Education to Undergraduates Using Virtual Hospital Education Resources.

  351. 数字金融与并购:实证研究与机制分析

    Digital finance and M&As: An empirical study and mechanism analysis.

  352. 文献综述:数字疫苗供应链支持技术的当前趋势与未来展望

    Literature review: Current trends and future prospects of digital vaccine supply chain support technology.

  353. 迈向低碳美丽世界:评估数字技术对减少污染和减少碳排放的共同利益的影响

    Towards a low-carbon and beautiful world: assessing the impact of digital technology on the common benefits of pollution reduction and carbon reduction.

  354. 澳大利亚北领地一个偏远原住民社区中用于健康和电子健康素养的数字技术使用:一项基于社区的研究

    Digital Technology Use for Health and eHealth Literacy in a Very Remote Aboriginal Community in the Northern Territory, Australia: A Community-Based Study.

  355. 北美颌面修复学的未来:先进数字技术与人工智能的作用——一份讨论文件

    The future of maxillofacial prosthodontics in North America: The role of advanced digital technology and artificial intelligence - A discussion document.

  356. 评估协作治理的效果:一个数字教育项目的案例

    Evaluating the effects of collaborative governance: Case of a digital education project.

  357. 数字技术在接触者追踪中的应用:COVID-19及以后的新希望?

    Digital technology applications for contact tracing: the new promise for COVID-19 and beyond?

  358. 理解使用数字技术共享患者生成健康数据用于长期健康状况患者的障碍与促进因素:叙述性综述

    Understanding the Barriers and Facilitators to Sharing Patient-Generated Health Data Using Digital Technology for People Living With Long-Term Health Conditions: A Narrative Review.

  359. 基于数字技术的严重游戏干预对轻度认知障碍老年人的影响:随机对照试验的荟萃分析

    Effects of digital technology-based serious games interventions for older adults with mild cognitive impairment: a meta-analysis of randomised controlled trials.

  360. 面向初级保健提供者和癌症专科医生的基于网络的沟通系统的实施

    Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists.

  361. 数字时代的青少年发展与日益扩大的鸿沟

    Adolescent development and growing divides in the digital age
.

  362. 建设数字技术在初级保健中的实际试验能力

    Building Capacity for Pragmatic Trials of Digital Technology in Primary Care.

  363. 大规模无线网络中灵活、类脑的通信

    Flexible, Brain-Inspired Communication in Massive Wireless Networks.

  364. 影响职业教育中数字技术获取的因素

    Factors affecting digital technology access in vocational education.

  365. 评估数字技术对口腔正畸头影测量学学习的效果

    Evaluating the effect of digital technology on the learning of orthodontic cephalometric measurement.

  366. 高管学术背景与企业数字化转型

    Academic background of senior executives and enterprise digital transformation.

  367. 数字技术在针对d...人群的非药物认知和心理社会干预中的应用 (原文已截断)

    The use of digital technology in non-pharmacological cognitive and psychosocial interventions for people with dementia and mild cognitive impairment: A scoping review.

  368. 多囊卵巢综合征女性的数字技术可及性与使用情况:范围综述

    Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review.

  369. 食管学中的新兴创新、人工智能与数字技术

    Emerging innovation, artificial intelligence, and digital technology in esophagology.

  370. 社区参与中的数字技术:影响与启示

    Digital Technology in Community Engagement: Impacts and Implications.

  371. 数字技术在本科和研究生医学教育中培养沟通技能的应用:范围综述

    Use of Digital Technology for Developing Communication Skills in Undergraduate and Postgraduate Medical Education: Scoping Review.

  372. 数字健康与技术

    Digital health and technologies.

  373. 数字技术在学习型医疗系统中的应用与作用:范围综述

    The use and role of digital technology in learning health systems: A scoping review.

  374. 匈牙利无家可归人群的数字技术获取与健康相关互联网使用:定量调查

    Digital Technology Access and Health-Related Internet Use Among People Experiencing Homelessness in Hungary: Quantitative Survey.

  375. 使用数字技术管理糖尿病足溃疡的促进因素与障碍:定性系统综述

    Facilitators and barriers of using digital technology for the management of diabetic foot ulcers: A qualitative systematic review.

  376. 数字技术在乳腺病理诊断和免疫组织化学中的应用

    Digital Technology in Diagnostic Breast Pathology and Immunohistochemistry.

  377. 探索职场灵性、正念、数字技术与心理健康:组织情境中的复杂交互作用

    Exploring workplace spirituality, mindfulness, digital technology, and psychological well-being: A complex interplay in organizational contexts.

  378. 肝母细胞瘤:肿瘤学综述

    Hepatoblastoma: an oncological review.

  379. 从高危肝母细胞瘤到癌的异步转变

    Asynchronous transitions from high-risk hepatoblastoma to carcinoma.

  380. 肝母细胞瘤——治疗及预后的演变以及切除肿瘤组织学的意义。40例31年经验

    Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.

  381. 剂量密集型多药化疗联合手术治疗儿童高危肝母细胞瘤的成功经验:SIOPEL-3HR研究的最终结果

    Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.

  382. 新辅助化疗后儿童肝母细胞瘤:MR在POSTTEXT分期和血管侵犯中的诊断效能

    Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement.

  383. 畸胎样肝母细胞瘤

    Teratoid hepatoblastoma.

  384. 荷兰儿童肝母细胞瘤的外科治疗(1990-2013年)

    Surgical treatment of childhood hepatoblastoma in the Netherlands (1990-2013).

  385. 依维莫司在儿童肝移植受者中的应用:单中心首次经验

    The use of everolimus in pediatric liver transplant recipients: first experience in a single center.

  386. 胸骨正中切开术用于儿童双侧肺转移灶切除术

    Median sternotomy for bilateral pulmonary metastasectomy in children.

  387. 舌缩小术对4例Beckwith-Wiedemann综合征患儿整体言语清晰度、构音及口颌面功能行为的影响

    Impact of tongue reduction on overall speech intelligibility, articulation and oromyofunctional behavior in 4 children with Beckwith-Wiedemann syndrome.

  388. 紫杉醇:治疗异种移植肝母细胞瘤的有效抗肿瘤药物

    Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma.

  389. 转移性和不可切除性肝母细胞瘤中EGFR-ASAP1信号的缺失

    Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.

  390. 光动力技术用于人肝母细胞瘤和神经母细胞瘤实验性治疗的体外和体内评估:初步结果

    In vitro and in vivo evaluation of photodynamic techniques for the experimental treatment of human hepatoblastoma and neuroblastoma: preliminary results.

  391. 不可切除肝母细胞瘤肝移植中的肾小球滤过率

    Glomerular filtration rate in liver transplant for unresectable hepatoblastoma.

  392. 采用日本儿童肝脏肿瘤研究组2方案治疗肝母细胞瘤的结局及晚期并发症

    Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.

  393. 供者移植物类型对儿童肝母细胞瘤肝移植术后生存的影响

    The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children.

  394. 取自受者颈外静脉的血管移植物在肝母细胞瘤患儿肝移植中形成门静脉-门静脉吻合:单中心经验

    Vascular Graft From the Recipient's External Jugular Vein to Form a Portoportal Anastomosis During Liver Transplant in a Child With Hepatoblastoma: a Single-Center Experience.

  395. 肝母细胞瘤切除术后的结果和并发症

    Outcome and complications after resection of hepatoblastoma.

  396. 肝母细胞瘤患儿治疗及预后的变迁:单中心过去20年经验分析

    Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.

  397. 不完全热消融诱导的转录因子核受体亚家族2、F组、成员6(NR2F6)上调促进肝母细胞瘤残留肝脏肿瘤的快速进展

    Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma.

  398. 肝母细胞瘤诊断和治疗的最新进展

    An update on diagnosis and treatment of hepatoblastoma.

  399. 不可切除及转移性肝母细胞瘤的治疗:儿童肿瘤学组II期研究

    Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.

  400. 一例儿科患者肝动脉化疗栓塞的麻醉管理

    Anaesthetic management of hepatic artery chemoembolization in a paediatric patient.

  401. 父母不孕、不孕治疗与肝母细胞瘤:来自儿童肿瘤协作组的报告

    Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

  402. 儿童胚胎性实体瘤患者肺转移的外科治疗:最新进展

    Surgical treatment of lung metastases in patients with embryonal pediatric solid tumors: an update.

  403. 累及儿童肝门巨大肝脏肿瘤的手术治疗

    Surgical management of giant liver tumor involving the hepatic hilum of children.

  404. 化疗前成功切除破裂的肝母细胞瘤:一例报告

    Successful resection of a ruptured hepatoblastoma prior to chemotherapy: report of a case.

  405. 日本活体供肝移植治疗肝母细胞瘤结局的全国性调查

    Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan.

  406. 无脾儿科患者中与肺炎链球菌败血症相关的暴发性紫癜

    Purpura fulminans associated with Streptococcus pneumoniae septicemia in an asplenic pediatric patient.

  407. 幼儿自体骨髓移植大剂量化疗后与人疱疹病毒-6再激活相关的血栓性微血管病

    Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children.

  408. 儿童恶性肝脏肿瘤手术治疗进展

    Progress in the surgical treatment of malignant liver tumors in children.

  409. 儿童肝细胞癌:国际儿科肿瘤学会协作组首次前瞻性研究结果

    Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group.

  410. 肝母细胞瘤:研究与治疗的最新进展

    Hepatoblastoma: recent developments in research and treatment.

  411. 日本初治切除肝母细胞瘤的死亡率和并发症发生率:JPLT(日本儿童肝脏肿瘤研究组)试验的经验

    Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.

  412. 硫代硫酸钠对顺铂所致听力损失的保护作用

    Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.

  413. 儿童肝脏肿瘤的当前概念

    Current concepts in pediatric liver tumors.

  414. 肝母细胞瘤手术策略和肝移植的最新进展

    Recent advances in surgical strategies and liver transplantation for hepatoblastoma.

  415. 肝移植术后获得性抗凝血酶IIb型缺乏症:一例报告

    Acquired antithrombin type IIb deficiency after liver transplantation: a case report.

  416. 超越米兰标准:儿童肝脏肿瘤的肝移植

    Beyond the Milan criteria for liver transplantation in children with hepatic tumours.

  417. 肝母细胞瘤

    Hepatoblastoma.

  418. 减重手术后的血栓预防

    Thromboprophylaxis after bariatric surgery.

  419. 3003例病态肥胖患者腹腔镜袖状胃切除术:高容量减重中心的结果

    Laparoscopic Sleeve Gastrectomy for Morbid Obesity in 3003 Patients: Results at a High-Volume Bariatric Center.

  420. 腹腔镜袖状胃切除术后肠系膜上静脉血栓形成的罕见并发症:病例报告

    A rare complication with superior mesenteric vein thrombosis after laparoscopic sleeve gastrectomy: A case report.

  421. 腹腔镜袖状胃切除术并发门肠系膜静脉血栓形成:病例系列

    Laparoscopic Sleeve Gastrectomy Complicated by Portomesenteric Vein Thrombosis: a Case Series.

  422. 接受腹腔镜袖状胃切除术的超肥胖患者的结果

    Outcomes in Super Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy.

  423. 腹腔镜袖状胃切除术,529例无漏:短期结果及技术考量

    Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations.

  424. 腹腔镜袖状胃切除术后两周发生门肠系膜静脉血栓形成、肠坏疽及双侧肺动脉栓塞

    Portomesenteric Vein Thrombosis, Bowel Gangrene, and Bilateral Pulmonary Artery Embolism Two Weeks after Laparoscopic Sleeve Gastrectomy.

  425. 腹腔镜袖状胃切除术与腹腔镜单吻合口胃旁路术对门静脉血流的早期影响:一项前瞻性队列研究

    Early Effects of Laparoscopic Sleeve Gastrectomy and Laparoscopic One-Anastomosis Gastric Bypass on Portal Venous Flow: a Prospective Cohort Study.

  426. 腹腔镜袖状胃切除术后门脾肠系膜血栓形成

    Portosplenomesenteric thrombosis after laparoscopic gastric sleeve.

  427. 机器人袖状胃切除术后门肠系膜血栓形成

    Portomesenteric thrombosis after robotic sleeve gastrectomy.

  428. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:1236例连续病例的发生率、分析与随访

    Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: Incidence, Analysis and Follow-Up in 1236 Consecutive Cases.

  429. 袖状胃切除术后门肠系膜静脉血栓形成:10年回顾

    Portomesenteric vein thrombosis in sleeve gastrectomy: a 10-year review.

  430. 袖状胃切除术后门肠系膜静脉血栓形成:一例病例报告及文献综述

    Portomesenteric Vein Thrombosis Following Sleeve Gastrectomy: A Case Report and Literature Review.

  431. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成

    Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy.

  432. 腹腔镜袖状胃切除术后急性内脏静脉血栓形成:一例病例报告

    Acute splanchnic venous thrombosis following laparoscopic sleeve gastrectomy: A case report.

  433. 腹腔镜三孔袖状胃切除术:单机构病例系列

    Laparoscopic Three-Port Sleeve Gastrectomy: A Single Institution Case Series.

  434. 袖状胃切除术后肠系膜静脉血栓形成:一例病例报告及文献综述

    Mesenteric Vein Thrombosis following Sleeve Gastrectomy: A Case Report and Review of the Literature.

  435. [机器人袖状胃切除术:单中心经验]

    [Robotic sleeve gastrectomy: single-center experience].

  436. 腹腔镜袖状胃切除术后门静脉血栓形成的表现症状、发生率及危险因素

    Presenting Symptoms, Incidence, and Risk Factors of Portal Vein Thrombosis After Laparoscopic Sleeve Gastrectomy.

  437. 腹腔镜袖状胃切除术后利伐沙班预防可降低门肠系膜静脉血栓形成的发生率

    Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis.

  438. 导管定向溶栓治疗腹腔镜袖状胃切除术后急性门肠系膜静脉血栓形成

    Catheter-Directed Thrombolysis in the treatment of acute Portomesenteric Vein Thrombosis after Laparoscopic Sleeve Gastrectomy.

  439. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:一例病例报告

    Portomesenteric Vein Thrombosis after Laparoscopic Sleeve Gastrectomy: A Case Report.

  440. 腹腔镜袖状胃切除术后门静脉血栓形成伴肠系膜静脉缺血:一例病例报告及文献综述

    Post laparoscopic sleeve gastrectomy portal vein thrombosis with venous mesenteric ischemia: a case report with literature review.

  441. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成。一例病例报告

    Porto-mesenteric vein thrombosis after laparoscopic sleeve gastrectomy. A case report.

  442. 腹腔镜袖状胃切除术后深静脉血栓形成及门肠系膜轴血栓形成的发生率

    Incidence of deep vein thrombosis and thrombosis of the portal-mesenteric axis after laparoscopic sleeve gastrectomy.

  443. 腹腔镜袖状胃切除术影响肥胖患者的凝血系统

    Laparoscopic Sleeve Gastrectomy Affects Coagulation System of Obese Patients.

  444. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:能量系统是否是这一罕见并发症的诱发因素?

    Portomesenteric Venous Thrombosis Post-Laparoscopic Sleeve Gastrectomy: Do Energy Systems Pose as Instigating Factor to This Infrequent Complication?

  445. 腹腔镜袖状胃切除术:澳大利亚单外科医生500例实践回顾

    Laparoscopic sleeve gastrectomy: review of 500 cases in single surgeon Australian practice.

  446. 腹腔镜袖状胃切除术当天出院与住院:系统评价和荟萃分析

    Same-day discharge vs. inpatient stay in laparoscopic sleeve gastrectomy: a systematic review and meta-analysis.

  447. 肠系膜上静脉血栓形成作为腹腔镜袖状胃切除术后罕见并发症:病例报告及文献综述

    Superior mesenteric vein thrombosis as uncommon complication following laparoscopic sleeve gastrectomy: a case report and literature review.

  448. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成是否与短程血栓栓塞预防有关?一项关于一种不常见但并非罕见并发症的单中心回顾性分析及文献综述

    Is Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy Related to Short-Course Prophylaxis of Thromboembolism? A Monocentric Retrospective Analysis About an Infrequent but Not Rare Complication and Review of the Literature.

  449. 经脐单切口腹腔镜袖状胃切除术

    Transumbilical single-incision laparoscopic sleeve gastrectomy.

  450. 血栓三联征:腹腔镜袖状胃切除术并发症

    Thrombus Trifecta: A Laparoscopic Sleeve Gastrectomy Complication.

  451. 出院后30天利伐沙班预防可防止腹腔镜袖状胃切除术后门肠系膜静脉血栓形成

    30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy.

  452. 腹腔镜袖状胃切除术后肠系膜静脉血栓形成

    Mesenteric vein thrombosis after laparoscopic sleeve gastrectomy.

  453. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:单机构报告

    Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: A Single-Institution Report.

  454. {“_”:“接受BARIATRIC手术的患者的围手术期营养、代谢和非手术支持的临床实践指南-2019年更新:由美国临床内分泌学家协会/美国内分泌学会、肥胖症学会、美国代谢和BARIATRICA手术学会、肥胖症医学会和美国麻醉师学会共同制定。”,“i”:[“执行摘要”]}

    {"_":"CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - .","i":["EXECUTIVE SUMMARY"]}

  455. 腹部普通外科、结直肠外科、上消化道外科和肝胆胰外科手术中特定术式血栓与出血风险的系统综述与荟萃分析

    Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery.

  456. 腹腔镜袖状胃切除术后的罕见并发症

    Rare Complications Following Laparoscopic Sleeve Gastrectomy.

  457. 病态肥胖患者腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:病例系列及文献综述

    Porto-mesenteric vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity: Case series and literature review.

  458. 腹腔镜袖状胃切除术和腹腔镜Roux-en-Y胃旁路术后门肠系膜静脉血栓形成:36例系列报告

    Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass: a 36-case series.

  459. 腹腔镜袖状胃切除术后门静脉血栓形成:表现与处理

    Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management.

  460. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:病例系列及文献综述

    Portomesenteric Vein Thrombosis Post-Laparoscopic Sleeve Gastrectomy: Case Series and Literature Review.

  461. 腹腔镜袖状胃切除术后门肠系膜静脉血栓形成:3例病例报告及文献综述

    Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: 3 Case Reports and a Literature Review.

  462. 环丙沙星预防性用药在儿科急性淋巴细胞白血病患者中的群体药代动力学和药效学

    Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients.

  463. 儿童癌症潜在肾毒性治疗后的早期和晚期肾脏不良反应

    Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

  464. 标准风险和高风险儿童及青少年对血脂筛查指南的依从性

    Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.

  465. 培门冬酶的个体化给药指南及影响清除率的因素:群体药代动力学模型

    Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.

  466. {"_":"斯洛文尼亚人群的基因图谱分析。","i":["NUDT15"]}

    {"_":"Genetic profiling of in the Slovenian population.","i":["NUDT15"]}

  467. 热量限制对接受新辅助化疗的癌症患者的影响:一项前瞻性病例对照研究

    Impact of Caloric Restriction in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Prospective Case Control Study.

  468. 难治性或复发性神经母细胞瘤患者化疗-免疫治疗方案评估:关键肿瘤学结局的系统评价与荟萃分析

    Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes.

  469. 赞比亚和南非自我报告的结核病治疗与全社区艾滋病毒和结核病筛查通用检测和治疗的发生率:对HPTN 071(PopART)集群随机试验的计划分析

    Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.

  470. 骨肉瘤患者化疗治疗反应和毒性的药物遗传学:一项系统综述

    Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review.

  471. 儿童患者放射治疗的远期效应与生存者管理

    Late effects of radiation therapy in pediatric patients and survivorship.

  472. 社区环境下儿童癌症患者中与临床实践指南不一致的化疗诱导呕吐预防:一项儿童肿瘤协作组研究

    Clinical practice guideline-inconsistent chemotherapy-induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study.

  473. 地努图希单抗β与那昔妥单抗在疾病稳定、轻微缓解或部分缓解且存在骨或骨髓病变的复发/难治性神经母细胞瘤患者治疗中的比较:系统评价与匹配调整间接比较

    Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.

  474. 安大略省HIV耐药检测、病毒抑制与死亡率之间的关联:一项回顾性队列研究

    The association between HIV drug resistance testing, viral suppression and mortality in Ontario: a retrospective cohort study.

  475. 乳腺癌生存者的心脏功能障碍:心脏毒性治疗与心血管危险因素的作用

    Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors.

  476. 实施预防性药物基因组学:早期药物基因组学筛查在1151名儿科肿瘤队列中的影响

    Implementing Pre-Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects.

  477. 大剂量甲氨蝶呤治疗对儿童癌症幸存者的晚期影响——一项系统综述

    Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.

  478. 支持移植中更昔洛韦治疗药物监测应用的证据

    Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation.

  479. 急性淋巴细胞白血病的药物遗传学:综合进展以实现个体化硫嘌呤治疗

    {"_":" Pharmacogenetics in Acute Lymphoblastic Leukemia: Synthesizing Progress for Personalized Thiopurine Therapy.","i":["NUDT15"]}

  480. ERN GENTURIS关于体质性错配修复缺陷诊断、遗传咨询、监测、生活质量和临床管理的指南

    ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management.

  481. 儿童和青少年鼻咽癌:EXPeRT/PARTNER诊断和治疗建议

    Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.

  482. 儿童急性髓系白血病化疗后中性粒细胞减少的门诊与住院管理的医疗结局、生活质量和家庭认知

    Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.

  483. 埃塞俄比亚慢性乙型肝炎治疗项目的五年结果

    Five-year results of a treatment program for chronic hepatitis B in Ethiopia.

  484. 妊娠期急性髓系白血病诊断和管理指南

    Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy.

  485. 佝偻病指导:第二部分管理

    Rickets guidance: part II-management.

  486. 重新定义儿科肿瘤学中的生存者身份:对长期问题的新视角

    Redefining Survivorship in Pediatric Oncology: A Fresh Look at a Long-Term Problem.

  487. 抗凝治疗:适应证、监测和并发症

    Anticoagulation therapy: indications, monitoring, and complications.

  488. 一次性疗法的循证价值评估:Tisagelecleucel案例研究

    Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study.

  489. 使用群体药代动力学在儿童白血病患者中选择isatuximab给药方案

    Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.

  490. 犹他州癌症幸存者的体力活动:基于人群的全州调查分析

    Physical Activity Among Utah Cancer Survivors: Analysis From a Population-Based Statewide Survey.

  491. 从月经到绝经的抗凝管理:临床管理工具包

    Anticoagulation stewardship from menstruation to menopause: a toolkit for clinical management.

  492. 肥胖儿童的化疗给药:文献综述与本地实践评估

    Dosing chemotherapy in children with obesity: literature review and evaluation of local practices.

  493. 印度儿童急性淋巴细胞白血病风险分层治疗的费用比较

    Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

  494. 合成代谢-雄激素类固醇的化学、生物学作用及临床应用综述

    A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids.

  495. 加拿大因流感住院儿童的抗病毒药物使用情况

    Antiviral Use in Canadian Children Hospitalized for Influenza.

  496. 长春新碱诱导的儿童上睑下垂:系统综述和实践建议

    Vincristine-induced ptosis in pediatric patients: a systematic review and practice recommendations.

  497. 7995例SARS-CoV-2感染患者的临床特征和结局

    Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.

  498. 止吐药:美国临床肿瘤学会临床实践指南更新

    Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

  499. 临床药物遗传学实施联盟基于TPMT和NUDT15基因型的硫嘌呤剂量指南:2018年更新

    Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

  500. 我应该服用阿司匹林吗?(SITA):癌症化学预防决策辅助工具的随机对照试验

    Should I Take Aspirin? (SITA): randomised controlled trial of a decision aid for cancer chemoprevention.